Lord, Abbett & Co’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-254,296
Closed -$9.06M 668
2020
Q2
$9.06M Buy
+254,296
New +$8.83M 0.03% 495
2017
Q3
Sell
-103,500
Closed -$4.2M 914
2017
Q2
$4.2M Buy
+103,500
New +$3.21M 0.01% 794
2016
Q4
Sell
-131,634
Closed -$2.67M 939
2016
Q3
$2.67M Sell
131,634
-68,340
-34% -$1.38M 0.01% 813
2016
Q2
$3.75M Sell
199,974
-58,453
-23% -$1.07M 0.01% 766
2016
Q1
$4.63M Buy
+258,427
New +$4.43M 0.01% 723

Other funds holding PETS

Lord, Abbett & Co's PETS Position: Q3 2020 in Review

Lord, Abbett & Co sold out of PetMed Express (PETS) in Q3 2020, closing a stake of 254,296 shares — an estimated $9.06M sold.

Lord, Abbett & Co first reported a position in PETS in Q1 2016 and held it in 5 quarters. The position peaked at $9.06M in Q2 2020. 201 funds tracked by Wall St. Rank hold PETS as of Q3 2020.

  • Lord, Abbett & Co reported no remaining PetMed Express position as of Q3 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 254,296 PetMed Express shares in Q3 2020, an estimated $9.06M.
  • Lord, Abbett & Co first reported a position in PetMed Express in Q1 2016 and held it in 5 quarters.
  • Lord, Abbett & Co's PetMed Express position peaked at $9.06M in Q2 2020.
  • 201 funds tracked by Wall St. Rank held PetMed Express as of Q3 2020.

Based on Lord, Abbett & Co's 13F filing for Q3 2020, filed 12 Nov 2020.